Oxidative deamination of
dopamine produces the highly toxic
aldehyde 3,4-dihydroxyphenylacetaldehyde (DOPAL), enhanced production of which is found in post-mortem brains of
Parkinson disease patients. When injected into the substantia nigra of rat brains, DOPAL causes the loss of dopaminergic neurons accompanied by the accumulation of potentially toxic oligomers of the presynaptic
protein α-
synuclein (aS), potentially explaining the synergistic toxicity described for
dopamine metabolism and aS aggregation. In this work, we demonstrate that DOPAL interacts with aS via formation of
Schiff-base and Michael-addition adducts with Lys residues, in addition to causing oxidation of Met residues to Met-
sulfoxide. DOPAL modification leads to the formation of small aS oligomers that may be cross-linked by DOPAL. Both monomeric and oligomeric DOPAL adducts potently inhibit the formation of mature
amyloid fibrils by unmodified aS. The binding of aS to either
lipid vesicles or
detergent micelles, which results in a gain of α-helix structure in its N-terminal
lipid-binding domain, protects the
protein against DOPAL adduct formation and, consequently, inhibits DOPAL-induced aS oligomerization. Functionally, aS-DOPAL monomer exhibits a reduced affinity for small
unilamellar vesicles with
lipid composition similar to synaptic vesicles, in addition to diminished membrane-induced α-helical content in comparison with the unmodified
protein. These results suggest that DOPAL could compromise the functionality of aS, even in the absence of
protein oligomerization, by affecting the interaction of aS with
lipid membranes and hence its role in the regulation of synaptic vesicle traffic in neurons.